United States · FDA National Drug Code directory
Spironolactone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59746-216_7839b797-5078-4aab-93a5-6056e4b9cdd5
- Product NDC
- 59746-216
- Form
- TABLET, FILM COATED
- Composition / generic term
- spironolactone
- Labeler
- Jubilant Cadista Pharmacuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130201
- Source listing expiry
- 20261231
Source-listed ingredients
- SPIRONOLACTONE — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (59746-216-01) · 59746-216-01
- 500 TABLET, FILM COATED in 1 BOTTLE (59746-216-05) · 59746-216-05
- 1000 TABLET, FILM COATED in 1 BOTTLE (59746-216-10) · 59746-216-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →